{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:51:54Z","timestamp":1790787114605,"version":"4.1.0"},"reference-count":82,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2017.00204","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T07:53:20Z","timestamp":1504166000000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Disparities in Cardiovascular Disease and Type 2 Diabetes Risk Factors in Blacks and Whites: Dissecting Racial Paradox of Metabolic Syndrome"],"prefix":"10.3389","volume":"8","author":[{"given":"Kwame","family":"Osei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudy","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,8,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/01.CIR.0000112379.88385.67","article-title":"Clinical management of metabolic syndrome: report of the American Heart Association\/National Heart, Lung, and Blood Institute\/American Diabetes Association conference on scientific issues related to management","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0140-6736(08)60602-9","article-title":"Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies","volume":"371","author":"Sattar","year":"2008","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2337\/diacare.28.2.385","article-title":"The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study","volume":"28","author":"McNeill","year":"2005","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","article-title":"Metabolic syndrome and risk of cardiovascular disease: a meta-analysis","volume":"119","author":"Galassi","year":"2006","journal-title":"Am J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1210\/jc.2006-0594","article-title":"Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease","volume":"91","author":"Meigs","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1475-2840-7-27","article-title":"Metabolic syndrome according to different definitions in a rapidly developing country of the African region","volume":"18","author":"Kelliny","year":"2008","journal-title":"Cardiovasc Diabetol"},{"key":"B7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome \u2013 a new world-wide definition. A consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00125-005-1689-3","article-title":"Metabolic Syndrome and coronary heart disease in South Asians, African-Caribbeans and White Europeans: a UK population-based cross-sectional study","volume":"48","author":"Tillin","year":"2005","journal-title":"Diabetologia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1089\/met.2008.0003","article-title":"The metabolic syndrome, insulin resistance and its surrogates in African and White subjects with type 2 diabetes in South Africa","volume":"6","author":"Kalk","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"B11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/CIRCULATIONAHA.104.520130","article-title":"Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in Whites and Blacks","volume":"112","author":"Lteif","year":"2005","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/000331979704800401","article-title":"Racial differences in risk factors for atherosclerosis. The ARIC study: Atherosclerosis Risk in Communities","volume":"48","author":"Hutchinson","year":"1997","journal-title":"Angiology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jacc.2005.04.046","article-title":"Increased subclinical atherosclerosis in young adults with metabolic syndrome. The Bogalusa Heart Study","volume":"46","author":"Tzou","year":"2005","journal-title":"J Am Coll Cardiaol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2007.10.013","article-title":"An international matched cohort study of the contribution of metabolic impairments to subclinical atherosclerosis in United Kingdom and Jamaican African-Caribbeans","volume":"199","author":"Kalra","year":"2008","journal-title":"Atherosclerosis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.2337\/diacare.27.11.2707","article-title":"Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) Study, 1985-2001","volume":"27","author":"Carnethon","year":"2004","journal-title":"Diabetes Care"},{"key":"B16","first-page":"830","article-title":"Metabolic syndrome in non-diabetic, obese first degree relatives of African American patients with type 2 diabetes. African American triglycerides-HDL-C and insulin resistance paradox","volume":"16","author":"Meis","year":"2006","journal-title":"Ethn Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.dsx.2014.04.026","article-title":"Clustering of cardiometabolic risk factors and risk of elevated HbA1c in non-Hispanic White, non-Hispanic Black and Mexican-American adults with type 2 diabetes","volume":"8","author":"Okosun","year":"2014","journal-title":"Diabetes Metab Syndr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.2337\/diacare.27.10.2444","article-title":"Increasing prevalence of the metabolic syndrome among US Adults","volume":"27","author":"Ford","year":"2004","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/archinte.163.4.427","article-title":"The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Survey. 1988-1994","volume":"24","author":"Park","year":"2003","journal-title":"Arch Intern Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US Adults. Findings from the Third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"788","DOI":"10.2337\/diacare.27.3.788","article-title":"Predictors of the incident Metabolic Syndrome in Adults","volume":"27","author":"Palaniappan","year":"2004","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jash.2008.07.003","article-title":"Independent role of blood pressure on cardiovascular risk factors in nondiabetic, obese African American Women: implications for metabolic syndrome thresholds","volume":"3","author":"Gaillard","year":"2009","journal-title":"J Am Soc Hypertens"},{"key":"B23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/JCN.0b013e318197aa3a","article-title":"Cardiometabolic risk among African American women: a pilot study","volume":"24","author":"Appel","year":"2009","journal-title":"J Cardiovasc Nurs"},{"key":"B24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.metabol.2008.09.007","article-title":"The atypical presentation of the metabolic syndrome components in Black African women: the relationship with insulin resistance and the influence of regional adipose tissue distribution","volume":"58","author":"Jennings","year":"2009","journal-title":"Metabolism"},{"key":"B25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1055\/s-2007-985394","article-title":"Metabolic syndrome risk in Black South African women","volume":"39","author":"Schutte","year":"2007","journal-title":"Horm Metab Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s00125-005-1950-9","article-title":"Differences in the association between type 2 diabetes and impaired microvascular function among Europeans and African Caribbeans","volume":"48","author":"Strain","year":"2005","journal-title":"Diabetologia"},{"key":"B27","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2337\/diab.45.6.742","article-title":"Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic Whites. The Insulin Resistance Atherosclerosis Study","volume":"45","author":"Haffner","year":"1996","journal-title":"Diabetes"},{"key":"B28","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00125-004-1381-z","article-title":"Beta cell function and its relation to insulin action in humans: a critical appraisal","volume":"47","author":"Ferrannini","year":"2004","journal-title":"Diabetologia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2337\/dc09-1115","article-title":"Insulin resistance, \u03b2-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study","volume":"33","author":"Lorenzo","year":"2010","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2337\/diabetes.46.1.63","article-title":"Insulin sensitivity and acute insulin responses in African Americans, non-Hispanic Whites and Hispanics and NIDDM: the Insulin Resistance and Atherosclerosis Study","volume":"46","author":"Haffner","year":"1997","journal-title":"Diabetes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1365-2362.1994.tb02029.x","article-title":"Minimal model analyses of insulin-sensitivity and glucose-dependent glucose disposal in Black and White Americans","volume":"24","author":"Osei","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1464-5491.1994.tb00349.x","article-title":"Ethnic differences in secretion, sensitivity and hepatic extraction of insulin in Black and White Americans","volume":"11","author":"Osei","year":"1994","journal-title":"Diabet Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/dmrr.273","article-title":"Higher fasting insulin but lower fasting C-peptide levels in African Americans in the US population","volume":"18","author":"Harris","year":"2002","journal-title":"Diabetes Metab Res Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.annepidem.2007.11.013","article-title":"High blood pressure and cardiovascular disease mortality risk among U.S. adults: the third National Health and Nutrition Examination Survey mortality follow-up study","volume":"18","author":"Gu","year":"2008","journal-title":"Ann Epidemiol"},{"key":"B35","unstructured":"Underlying Cause of Death 1999-2013 on CDC WONDER Online Database, Released 2015. Data Are from the Multiple Cause of Death Files, 1999-2013, as Compiled from Data Provided by the 57 Vital Statistics Jurisdictions through the Vital Statistics Cooperative Program2017"},{"key":"B36","volume-title":"Hypertension among Adults in the US: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief, No. 133","author":"Nwankwo","year":"2013"},{"key":"B37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0895-4356(99)00208-5","article-title":"Diabetes Mellitus, coronary heart disease incidence, and death from all cause in African American and European American women. The NHANES I Epidemiologic Follow-up Study","volume":"53","author":"Gillum","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/archinte.167.7.642","article-title":"Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity","volume":"167","author":"McLaughlin","year":"2007","journal-title":"Arch Intern Med"},{"key":"B39","doi-asserted-by":"crossref","unstructured":"IDF Diabetes Atlas2015","DOI":"10.1016\/j.diabres.2015.05.037"},{"key":"B40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12916-016-0709-0","article-title":"Obesity and type 2 diabetes in sub-Saharan Africans \u2013 is the burden in today\u2019s Africa similar to African immigrants in Europe? The RODAM study","volume":"14","author":"Agyemang","year":"2016","journal-title":"BMC Med"},{"key":"B41","first-page":"176","article-title":"Racial differences of lipoprotein subclass distributions in postmenopausal women","volume":"18","author":"Vora","year":"2008","journal-title":"Ethn Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.113.002671","article-title":"High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy","volume":"128","author":"Mora","year":"2013","journal-title":"Circulation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.2337\/dc09-0380","article-title":"In vivo insulin sensitivity and lipoprotein particle size and concentration in Black and White children","volume":"32","author":"Burns","year":"2009","journal-title":"Diabetes Care"},{"key":"B44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2006.05.007","article-title":"LDL particle subclasses, LDL particle size and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"192","author":"Mora","year":"2007","journal-title":"Atherosclerosis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.amjcard.2015.01.015","article-title":"Relation of Black Race between high density lipoprotein cholesterol content, high density lipoprotein particles and coronary events (from the Dallas Heart Study)","volume":"115","author":"Chandra","year":"2015","journal-title":"Am J Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.metabol.2005.07.011","article-title":"Lipoprotein subclass and particle size differences in Afro-Caribbeans, African Americans and White Americans: association with hepatic lipase gene variation","volume":"55","author":"Mijkovic-Gacic","year":"2006","journal-title":"Metabolism"},{"key":"B47","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00439-012-1256-1","article-title":"Genetic variants associated with VLDL, LDL, and HDL particle size differ by race and ethnicity","volume":"132","author":"Frazier-Woods","year":"2013","journal-title":"Hum Genet"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e000246","DOI":"10.1136\/bmjdrc-2016-000246","article-title":"Ethnic differences in lipids and lipoproteins in overweight\/obese African American and White American women with prediabetes: significance of NMR-derived lipoprotein particle concentrations and sizes","volume":"4","author":"Gaillard","year":"2016","journal-title":"BMJ Open Diab Res Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/01.CIR.90.3.1185","article-title":"Serum lipoproteins in African Americans and Whites with noninsulin-dependent diabetes in the U.S. population","volume":"90","author":"Cowie","year":"1991","journal-title":"Circulation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-7-4","article-title":"Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race\/ethnicity?","volume":"7","author":"Li","year":"2008","journal-title":"Cardiovasc Diabetol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.metabol.2005.03.001","article-title":"Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase","volume":"54","author":"Sumner","year":"2005","journal-title":"Metabolism"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1001\/archinte.165.12.1395","article-title":"Fasting triglycerides and the triglyceride-HDL-Cholesterol ratio are not markers of insulin resistance in African Americans","volume":"165","author":"Sumner","year":"2005","journal-title":"Arch Intern Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1023\/A:1007492202045","article-title":"A review on ethnic difference in plasma triglycerides and high density lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rates in people of African origins?","volume":"14","author":"Zoratti","year":"1998","journal-title":"Eur J Epidemiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","article-title":"High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"60","author":"Mackey","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.atherosclerosis.2006.08.037","article-title":"Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant","volume":"193","author":"Fezeu","year":"2007","journal-title":"Atherosclerosis"},{"key":"B56","first-page":"1","article-title":"Determinants of insulin \u2013resistant phenotypes in normal weight and obese Black African Women","volume":"10","author":"Jennings","year":"2008","journal-title":"Obesity"},{"key":"B57","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2265.2006.02505.x","article-title":"The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African women","volume":"64","author":"Crowther","year":"2006","journal-title":"Clin Endocrinol"},{"key":"B58","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/ajcn.81.2.409","article-title":"Race-ethnicity\u2013specific waist circumference cutoffs for identifying cardiovascular disease risk factors","volume":"81","author":"Zhu","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"B59","first-page":"S97","article-title":"Oseisty in adult residents of Accra, Ghana","volume":"13","author":"Amoah","year":"2003","journal-title":"Ethn Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.2337\/dc07-1810","article-title":"Distinct component profiles and high risk among African Americans with the metabolic syndrome: the Jackson Heart Study","volume":"31","author":"Taylor","year":"2008","journal-title":"Diabetes Care"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jama.286.10.1195","article-title":"The continuing epidemics of obesity and diabetes in the United States","volume":"286","author":"Mokdad","year":"2001","journal-title":"JAMA"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.2337\/diacare.27.9.2222","article-title":"Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual","volume":"27","author":"St-Ong","year":"2004","journal-title":"Diabetes Care"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0026-0495(96)90011-6","article-title":"Abdominal fat distribution and metabolic risk factors: effects of race","volume":"45","author":"Lovejoy","year":"1996","journal-title":"Metabolism"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0026-0495(96)90011-6","article-title":"Visceral fat and race dependant health risk factors. Effect of race","volume":"45","author":"Albu","year":"1996","journal-title":"Metabolism"},{"key":"B65","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0005-2760(90)90314-N","article-title":"High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein","volume":"1044","author":"Parthasarathy","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"B66","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0021-9150(93)90183-U","article-title":"Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase","volume":"104","author":"Mackness","year":"1993","journal-title":"Atherosclerosis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2005.08.026","article-title":"Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes","volume":"187","author":"Rosenblat","year":"2006","journal-title":"Atherosclerosis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J Clin Invest"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.2337\/dc10-1189","article-title":"HDL dysfunctionality (paraoxonase) is worse in nondiabetic, postmenopausal African American than in White women","volume":"34","author":"Gaillard","year":"2011","journal-title":"Diabetes Care"},{"key":"B70","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijcard.2007.12.019","article-title":"Can dysfunctional HDL explain high coronary artery disease risk in South Asians?","volume":"129","author":"Dodani","year":"2008","journal-title":"Int J Cardiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1161\/01.CIR.89.6.2525","article-title":"Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis","volume":"89","author":"Zeiher","year":"1994","journal-title":"Circulation"},{"key":"B72","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1006\/bbrc.2000.2877","article-title":"High-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosis","volume":"272","author":"Sugano","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1055\/s-2005-870580","article-title":"The relationship between insulin sensitivity and serum adiponectin levels in three population groups","volume":"11","author":"Ferris","year":"2005","journal-title":"Horm Metab Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2003.07.002","article-title":"Ethnic differences in adiponectin levels","volume":"53","author":"Hulver","year":"2004","journal-title":"Metabolism"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.2337\/diabetes.53.9.2473","article-title":"Adiponectin and the development of type 2 diabetes. The Atherosclerosis Risk in Communities Study","volume":"53","author":"Duncan","year":"2004","journal-title":"Diabetes"},{"key":"B77","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/oby.2005.23","article-title":"Plasma adiponectin in first degree relatives of African Americans parents with type 2 diabetes with normal glucose tolerance, impaired glucose tolerance and type 2 diabetes","volume":"13","author":"Osei","year":"2005","journal-title":"Obes Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/nm.3385","article-title":"Racial difference in human platelet PAR4 reactivity reflects expression of PCTP and miR-376c","volume":"19","author":"Edelstein","year":"2013","journal-title":"Nat Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1617-9625-10-9","article-title":"Smoking status and metabolic syndrome in the Multi-Ethnic Study of Atherosclerosis. A cross-sectional study","volume":"10","author":"Berlin","year":"2012","journal-title":"Tob Induc Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.amjcard.2004.01.067","article-title":"C-Reactive protein levels among women of various ethnic groups living in the United States (from the Women\u2019s Health Study)","volume":"93","author":"Albert","year":"2004","journal-title":"Am J Cardiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1161\/ATVBAHA.115.306683","article-title":"Lipoprotein(a) levels are associated with subclinical calcific aortic valve disease in White and Black individuals: the Multi-Ethnic Study of Atherosclerosis","volume":"36","author":"Cao","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jvs.2015.08.114","article-title":"Sex and ethnic differences in the associations between lipoprotein(a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis","volume":"63","author":"Forbang","year":"2016","journal-title":"J Vasc Surg"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00204\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T23:54:39Z","timestamp":1570060479000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00204\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,31]]},"references-count":82,"alternative-id":["10.3389\/fendo.2017.00204"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2017.00204","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,31]]},"article-number":"204"}}